ISIda Sperle

Ida Sperle

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ida Sperle has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Thirty years of an advanced field epidemiology training programme: a mixed-methods evaluation, Germany, 1996 to 2025

    by Simon Brinkwirth, Lena Ella Schneider, Ida Sperle, Petra von Berenberg-Gossler, Katharina Alpers, Sofie Gillesberg Lassen

    INTRODUCTION: Field epidemiology training programmes (FETPs) strengthen public health workforce capacity for infectious disease surveillance and outbreak response. The Postgraduate Training for Applied Epidemiology (PAE) is a 2-year FETP aligned with European and global training standards. AIM: We evaluated the contribution of PAE to a strengthened public health workforce for infection protection in Germany. METHODS: Our evaluation consisted of three components: a semi-structured desk review of programme outputs (1996–2025), an online graduate survey (cohorts 1996–2023), and an online workshop with experts from local, federal state and national health authorities. We analysed quantitative data descriptively, and qualitative data through a simplified content analysis. RESULTS: By December 2025, PAE had 126 graduates with the following outputs: 197 peer-reviewed publications, 193 accepted conference abstracts, and 205 conducted outbreak investigations. In total, 72% (91/126) graduates responded to the survey. Most respondents remained in the German public health workforce (70%; 64/91), reported high satisfaction (90%; 82/91), and would recommend the programme (96%; 87/91). Graduates reported roles in crisis and outbreak management (70%; 64/91), holding leadership roles (59%; 54/91), and engaging in knowledge dissemination (86%; 78/91). Qualitative findings highlighted shared methodological approaches and technical language, and strong networks as key facilitators of collaboration across all levels of the German public health service. CONCLUSION: We found that PAE contributes to strengthening and sustaining an infection protection workforce in Germany that regularly applies and disseminates learnt skills. Most graduates have held or currently hold leadership roles and frequently contribute to outbreak and public health crisis management.

  • Open Access

    Barriers and facilitators to HIV and viral hepatitis testing in primary healthcare settings in the Kyrgyz Republic: A mixed-methods study using the COM-B Framework

    by Ida Sperle, Nikolay Lunchenkov, Anastassiya Stepanovich-Falke, Zuridin S. Nurmatov, Aybek A. Bekbolotov, Aisuluu Bolotbaeva, Aman Taalaibekov, Zamira Abdrakhmanova, Zulpueva Akmaral Aidarbekovna, Michael Brandl, et al.

    Introduction: The Kyrgyz programme on the elimination of HIV and ending AIDS and viral hepatitis infections (2023–2027) recognizes the need to scale up testing and include primary healthcare. Our aim was to identify and analyse important barriers and facilitators to HIV and hepatitis B, C and D testing from the perspective of medical doctors working in primary healthcare in the Kyrgyz Republic. Methods: We conducted a cross-sectional, mixed-methods study in the Kyrgyz Republic from June to November 2024, and first conducted in-depth semi-structured interviews. We applied a thematic analysis for qualitative analysis. We developed a questionnaire based on these main themes, which was distributed to medical doctors working in primary healthcare. A descriptive analysis of the questionnaire data followed. Results: Through 21 interviews, we identified training gaps, lack of knowledge, lack of time and physical space as well as social and cultural perceptions as key barriers. Data from 1,080 questionnaire responses (89% female; 46% 61 years or older) supported this with 35% reporting lack of time, 39% lack of doctors, and over 60% indicating need for further training. Identified facilitators included knowledge of guidelines, new technologies, e.g., self-testing, and the possibility of linking testing to hepatitis B vaccination. Questionnaire data confirmed access to free testing and treatment (HIV: 86%, viral hepatitis 89%), knowledge of testing indications (HIV: 80%, viral hepatitis: 76%), and linkage to vaccination (71%) as important facilitators. Lack of experience with key populations was evident with 78% not identifying any members of key populations as patients. Conclusion: To increase testing and reach the goals of ending AIDS and the epidemics of viral hepatitis, doctors in primary healthcare need capacity-building in the form of HIV and viral hepatitis training and knowledge dissemination to offer testing. Moreover, the availability and distribution of doctors in primary healthcare need to be prioritized and enhanced in areas in most need of care to ensure access to testing for all in the Kyrgyz Republic.


  • Open Access

    Developing a tailored bio-behavioural survey on viral hepatitis among migrants: mixed-methods preparations for the HepMig pilot study, Germany, July 2022–March 2023

    by Anna-Lisa Behnke, Ida Sperle, Gyde Steffen, Navina Sarma, Anastassiya Stepanovich-Falke, Sandra Dudareva, Ruth Zimmermann, Leman Bilgic, Münevver Demir, Claudia Hövener, et al.

    Objective: Migrants in Germany from countries with a high prevalence of viral hepatitis may need improved access to healthcare services but have not been adequately included in health surveys so far. The HepMig pilot study aims to develop and pilot an integrated bio-behavioural survey on viral hepatitis among migrants from high-prevalence countries living in Germany. The design should be robust, acceptable, feasible, non-stigmatising, non-discriminatory, and community-centred. This paper describes the preparatory research that informed the pilot study design. Results: We defined our populations of interest as adults (≥ 18 years) born in Bulgaria, Romania, Russia, Syria, or Türkiye living in Germany, irrespective of current citizenship or residence status. Analysis of sociodemographic data from the Federal Statistical Office (DESTATIS) revealed considerable differences between these populations in age distribution, duration of residence, and geographic distribution in Germany. An inductive analysis of information provided by community experts – who shared the same country of birth and /or history of migration or closely worked with the populations in focus – from clinical medicine, academia, non-governmental organizations, and public health identified four themes: (i) sampling of heterogeneous populations of interest; (ii) accessibility and trustworthiness as prerequisites for study participation; (iii) opportunities for community engagement and empowerment; and (iv) ethical considerations. Results will inform sampling, recruitment, data collection, and piloting the study design.

  • Open Access

    Standardising monitoring data on drug-related infectious diseases among people who inject drugs in Europe – an update of the European Union Drugs Agency technical protocol, 2024

    by Ida Sperle, Thomas Seyler, Filippo Pericoli, Erika Duffell, Sharon Hutchinson, Marie Jauffret-Roustide, Martin Kåberg, Anda Ķīvīte-Urtāne, Carole Seguin-Devaux, Vana Sypsa, et al.

    Drug-related infectious diseases (DRID), such as HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV), contribute to high morbidity and mortality among people who inject drugs (PWID). The European Union Drugs Agency (EUDA) is responsible for monitoring DRID and related behaviours for PWID in Europe. We updated the EUDA DRID technical protocol which covers all steps from planning to data analysis needed for a survey among PWID. Drug-related infectious disease-specific indicators were revised. To enable a more effective monitoring of the current epidemiological situation, we added specific core indicators, such as prevalence of viraemic HBV, HCV and HIV care cascades and harm reduction-related indicators. HIV pre-exposure prophylaxis and take-home naloxone were added as optional indicators. The process was informed by a European working group, who shared best-practice examples of (repeated) cross-sectional and cohort surveys using different methods in various settings. To reach the World Health Organization’s goal of ending HIV and the viral hepatitis epidemics, comprehensive DRID monitoring among the disproportionately affected PWID population is needed.